Literature DB >> 6600893

Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency.

J E Gadek, R G Crystal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6600893     DOI： 10.1164/arrd.1983.127.2P2.S45

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  5 in total

1.  Alpha-1-antitrypsin augmentation treatment: does one size fit all?

Authors:  J Stolk
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

2.  Biochemical reaction of alpha 1 antitrypsin during the substitution therapy of patients with homozygote PI-ZZ deficit.

Authors:  A Gillissen; E W Schmidt; B Rasche; W T Ulmer
Journal:  Klin Wochenschr       Date:  1989-03-15

Review 3.  Elastin and the lung.

Authors:  B C Starcher
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

4.  High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice.

Authors:  A L Archibald; M McClenaghan; V Hornsey; J P Simons; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency.

Authors:  J Rakela; M Goldschmiedt; J Ludwig
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.